Integrated network pharmacology and experimental analysis unveil multi-targeted effect of 18α- glycyrrhetinic acid against non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is one of the most malignant types of cancer with soaring incidence rates worldwide, attributed to its heterogeneity and complex etiology. Evidently, alternative anti-cancer therapies comprising traditional medicines and natural products have gained attention for t...
Main Authors: | Rasha Irshad, Nafis Raj, Gamal A. Gabr, Nikhat Manzoor, Mohammad Husain |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1018974/full |
Similar Items
-
Pharmacological Features of 18β-Glycyrrhetinic Acid: A Pentacyclic Triterpenoid of Therapeutic Potential
by: Pottathil Shinu, et al.
Published: (2023-03-01) -
versatility of 18β-glycyrrhetinic acid in attenuating pulmonary inflammatory disorders
by: Mohamad Siddiq Bin Mohamad, et al.
Published: (2023-02-01) -
18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice
by: Jintao Gao, et al.
Published: (2020-06-01) -
Exploring New Structural Features of the 18β-Glycyrrhetinic Acid Scaffold for the Inhibition of Anaplastic Lymphoma Kinase
by: Dong Cai, et al.
Published: (2019-10-01) -
Anti-Photoaging Effects of Nanocomposites of Amphiphilic Chitosan/18β-Glycyrrhetinic Acid
by: Weiyan Quan, et al.
Published: (2023-05-01)